Applied DNA Sciences, Inc.

DB:UDJ Stock Report

Market Cap: €3.8m

Applied DNA Sciences Management

Management criteria checks 4/4

Applied DNA Sciences' CEO is James Hayward, appointed in Apr 2006, has a tenure of 18.25 years. total yearly compensation is $468.00K, comprised of 96.2% salary and 3.8% bonuses, including company stock and options. directly owns 0.066% of the company’s shares, worth €2.48K. The average tenure of the management team and the board of directors is 9.4 years and 8.4 years respectively.

Key information

James Hayward

Chief executive officer

US$468.0k

Total compensation

CEO salary percentage96.2%
CEO tenure18.3yrs
CEO ownership0.07%
Management average tenure9.4yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has James Hayward's remuneration changed compared to Applied DNA Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$13m

Dec 31 2023n/an/a

-US$7m

Sep 30 2023US$468kUS$450k

-US$10m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022n/an/a

-US$7m

Sep 30 2022US$2mUS$450k

-US$8m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021n/an/a

-US$14m

Sep 30 2021US$1mUS$400k

-US$14m

Jun 30 2021n/an/a

-US$14m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020n/an/a

-US$15m

Sep 30 2020US$451kUS$133k

-US$13m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$9m

Dec 31 2019n/an/a

-US$8m

Sep 30 2019US$375kUS$233k

-US$9m

Jun 30 2019n/an/a

-US$11m

Mar 31 2019n/an/a

-US$12m

Dec 31 2018n/an/a

-US$12m

Sep 30 2018US$481kUS$250k

-US$12m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$11m

Dec 31 2017n/an/a

-US$12m

Sep 30 2017US$546kUS$282k

-US$13m

Compensation vs Market: James's total compensation ($USD468.00K) is about average for companies of similar size in the German market ($USD499.33K).

Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.

CEO

James Hayward (70 yo)

18.3yrs

Tenure

US$468,000

Compensation

Dr. James A. Hayward, Ph D., Sc D., has been Chief Executive Officer and Chairman of Applied DNA Sciences, Inc. (Formerly Known as Prohealth Medical Tech, Inc) since March 17, 2006 and since June 12, 2007...

Leadership Team

NamePositionTenureCompensationOwnership
James Hayward
Chairman18.3yrsUS$468.00k0.066%
€ 2.5k
Beth Jantzen
Chief Financial Officer9.4yrsUS$501.00k0.020%
€ 759.3
Judith Murrah
COO, Chief Information Officer & Secretary11.1yrsUS$542.75k0.023%
€ 865.6
Clay Shorrock
Chief Legal Officer & Executive Director of Business Development3.3yrsUS$501.00k0.027%
€ 1.0k
Sanjay Hurry
Executive Director of Investor Relations & Corporate Communications4yrsno datano data

9.4yrs

Average Tenure

57yo

Average Age

Experienced Management: UDJ's management team is seasoned and experienced (9.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
James Hayward
Chairman18.8yrsUS$468.00k0.066%
€ 2.5k
Robert Catell
Chairman of Strategic Advisory Board & Independent Director8.4yrsUS$152.50k0.00095%
€ 35.9
Yacov Shamash
Independent Director18.3yrsUS$162.50k0.00077%
€ 29.1
Raymond Kelly
Member of Strategic Advisory Board7.5yrsno datano data
Joseph Ceccoli
Independent Director9.6yrsUS$155.00k0.00027%
€ 10.2
Sanford Simon
Independent Director18.3yrsUS$151.25k0.000040%
€ 1.5
Mehmood Khan
Member of Strategic Advisory Board7.8yrsno datano data
Gunther Faber
Member of Strategic Advisory Board8.4yrsno datano data
Elizabeth M. Shaheen
Independent Director7.1yrsUS$153.75k0.00038%
€ 14.4
Stephen Birkhold
Member of Strategic Advisory Board5.5yrsno datano data

8.4yrs

Average Tenure

73yo

Average Age

Experienced Board: UDJ's board of directors are considered experienced (8.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/22 17:45
End of Day Share Price 2024/04/24 00:00
Earnings2024/03/31
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Applied DNA Sciences, Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jan WaldBenchmark Company
Matthew MillerCFRA Equity Research
Yi ChenH.C. Wainwright & Co.